A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor γ 2 gene with obesity in native Javanese in Indonesia

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 5, 2005, Pages 465-469

  Danawati, C W ^a,d   Nagata, M ^a   Moriyama, H ^a   Hara, K ^a   Yasuda, H ^a   Nakayama, M ^a   Kotani, R ^a   Yamada, K ^a   Sakata, M ^a   Kurohara, M ^a   Wiyono, P ^d   Asdie, H ^d   Sakaue, M ^b   Taniguchi, H ^c   Yokono, K ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF HYOGO   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Javanese; Obesity; PPAR 2 gene; Pro12Ala polymorphism; Type 2 diabetes mellitus

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; AGED; ALLELE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDONESIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALANINE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDONESIA; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PPAR GAMMA; PROLINE;

EID: 24944541350     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.543     Document Type: Article

References (25)

1. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med 2003; 228: 1111-1117.
2. Stumvoll M, Haring H. Perspectives in Diabetes: The peroxisome proliferator-activated receptor γ2 Pro12Ala polymorphism. Diabetes 2002; 50: 2341-2347.
3. Barroso I, Gurnell M, Crowley VEF, et al. Dominant negative mutations in human PPAR γ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402(6764): 880-883.
4. Hara K, Okada T, Tobe K, et al. The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commen 2000; 271: 212-216.
5. Werman A, Hollenberg A, Solanes G, et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptorγ (PPARγ differential activity of PPAR γ1 isoforms and influence of insulin. J Biol Chem 1997; 272: 20230-20235.
6. Auwerx J. PPARγ the ultimate thrifty gene. Diabetologia 1999; 42: 1033-1049.
7. Fajas L, Auboeuf D, Raspe E, et al. The organization, promoter analysis, and expression of the human PPAR γ gene. J Biol Chem 1997; 272: 18 779-18 789.
8. Giusti V, Verdumo C, Suter M, Gaillard RC, Burckhardt P, Pralong F. Expression of PPAR γ1 and PPAR γ2 in visceral and subcutaneous adipose tissue of obese women. Diabetes 2003; 52: 1673-1676.
9. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPAR γ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 2004; 20: 284-287.
10. Frederiksen L, Broadbaek K, Fenger M, et al. Comment: Studies of the Pro12Ala polymorphism of the PPAR gene in the Danish MONICA cohort: Homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 2002; 87: 3989-3992.
11. Mori H, Ikegami H, Kawaguchi Y, et al. Brief genetics report the Pro12 → Ala substitution in PPARγ is associated with resistance to development of diabetes in the general population possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 2001; 50: 891-894.
12. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
13. Masud S, Ye S, SAS group. Effect of the peroxisome proliferator-activated receptor γ2 Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 2003; 40: 773-780.
14. Beamer BA, Yen C-J, Andersen RE, et al. Brief genetics report: Association of the Pro12Ala variant in the PPAR γ2 gene with obesity in two Caucasian populations. Diabetes 1998; 47: 1806-1809.
15. Tai ES, Corella D, Yap MD, et al. Differential effects of the C1431T and Pro12Ala PPAR γ gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res 2004; 45: 674-685.
16. Oh EY, Min KM, Chung JH, et al. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor γ2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 2000; 85: 1801-1804.
17. Muller YL, Bogardus C, Beamer BA, Shuldiner AR, Baier IJ. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes 2003; 52: 1864-1871.
18. Rosmond R, Chagnon M, Bouchard C. The Pro12Ala PPAR γ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab Res Rev 2003; 19: 159-163.
19. -2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. J Eur Endocrinol 2002; 147: 495-501.
20. Sutanegara D, Darmono, Budhiarta AAG. The epidemiology and management of diabetes mellitus in Indonesia. Diabetes Res Clin Pract 2000; 50(Suppl. 2): S9-S16.
21. de Pablos-Velasco PL, Martinez-Martin FJ, Rodriguez-Perez A, et al. Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population-comparison of the 1997 ADA and the 1985 WHO criteria. The Guia study. Diabet Med 2001; 18: 235-241.
22. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MIJ. Effect of the Pro12Ala polymorphism of the PPAR γ2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 2001; 44: 925-926.
23. Hasstedt SJ, Ren Q-F, Teng K, Elbein SC. Effect of the peroxisome proliferators-activated receptor-γ2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial Type 2 diabetic kindreds. J Clin Endocrinol Metab 2001; 86: 536-541.
24. Luan J, Browne PO, Harding AH, et al. Evidence for Gene-nutrient Interaction at the PPAR γ locus. Diabetes 2001; 50: 686-689.
25. Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A, et al. Peroxisome proliferators-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension. J Hypertens 2003; 21: 1649-1655.